Navigation Links
Retina Implant AG Clinical Trial Results Presented at the 2013 American Academy of Ophthalmology Annual Meeting
Date:11/18/2013

g was quite an honor," said Dr. Katarina Stingl, clinical scientist from the Centre for Ophthalmology, University of Tuebingen, Germany. "After years of research we are finally able to provide a path to restore parts of functional vision for people suffering from end-stage retinitis pigmentosa, a degenerative disease that most often leads to blindness. It's been thrilling to be part of this ground breaking research, and it's a privilege to share our learnings with my esteemed peers."

"A lot of progress has been made in the decade since Retina Implant was born. Our success is due, in large part, to outstanding researchers, like Dr. Stingl, who have led our clinical trials," said Walter-G Wrobel, CEO of Retina Implant AG. "Our immediate focus is to expand access to our technology within the European Union as well in other parts of the world, including working with the FDA to approve a trial in the U.S."

The Alpha IMS is a 3x3 mm2 wireless subretinal microchip with 1,500 electrodes implanted below the retina, specifically in the macular region. The Alpha IMS provides artificial vision in implanted patients partly by taking over, in part, the function of the photoreceptors within the eye and transmitting the visual image in the form of electrical signals to the bipolar cells.

About Retinitis Pigmentosa
Retinitis pigmentosa (RP) is one of the most common forms of inherited retinal degenerations affecting 1.5 million worldwide. A progressive condition that gets worse over time, RP typically causes severe vision problems in adulthood. Retinal implants represent promise for enabling RP patients to regain functional sight.

About Retina Implant AG
Retina Implant AG is the leading developer of subretinal implants for partially sighted and blind patients. After extensive research with German university hospitals and institutes which began with a large grant from the G
'/>"/>

SOURCE Retina Implant AG
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress
3. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
4. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
5. India Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
6. United States Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
7. Asia-Pacific Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
8. Leading Researchers in Vision Impairment and Blindness to Present at EURETINA Winter Meeting
9. United Kingdom Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
10. Brazil Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
11. Australian Government Invests in Detection and Management of Blinding Eye Disease and Diabetes Through Intelligent High Resolution Retinal Camera Development by Vision CRC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... update and report second quarter 2014 financial results before ... 1, 2014. That same day, Arena will host a ... (5:30 a.m. Pacific Time). The conference ... callers and 914.495.8552 for international callers. Please specify to ...
(Date:7/24/2014)... , July 24, 2014  Parnell Pharmaceuticals Holdings ... that will be added to Parnell,s already extensive ... Pty Ltd, a biotechnology company. The compounds now ... shown promise in bone regeneration and dermal regeneration, ... the compounds for the veterinary market with the ...
(Date:7/24/2014)... Deutschland, und MARSEILLE , ... , Weltweite Exklusivlizenz der ... QIAGEN die Entwicklung von Tests auf SF3B1-Mutationen, ... Neuer Test weist Mutationen des ... (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Aug. 10 More than 33% of,pharmaceutical ... clinical,investigators 50% faster than their industry peers. ... trial costs while improving quality,by employing on-going ... research probing clinical trial excellence by,pharmaceutical consulting ...
... 10 Study results recently,published in the ... Imaging (BSGI) provides higher sensitivity for the,detection ... mammography or MRI and,can reliably detect small, ... Rachel Brem and colleagues at The George ...
Cached Medicine Technology:Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management 2BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ 2BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ 3BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ 4
(Date:7/25/2014)... 25, 2014 Bedros Keuilian has been ... in the country, and is considered the industry’s leading ... on his coaching website, RenegadeMarketing.com, he explains why information ... a good personal trainer. , “I’ve been really privileged ... leaders in the fitness industry and I’ve helped many ...
(Date:7/25/2014)... for Medical Oncology (ESMO), the leading pan-European association ... the proposed EU General Data Protection Regulation [1] ... significant burden to both doctors and cancer patients. ... stipulates ,explicit and specific patient consent, meaning that ... time research is planned in order to consult ...
(Date:7/25/2014)... Seattle, Wa (PRWEB) July 25, 2014 ... More Pdf review recently updated by Vkool.com, ... teach people how to treat some common ...     External hemorrhoids and internal hemorrhoids , ... after pregnancy with hemorrhoids ,     Very ...
(Date:7/25/2014)... As the category creator and world leader in healthy ... transform and improve individual lives worldwide through its exclusive and ... a successful Austin, Texas based "Xocai Activ Drink" author, is ... July to promote the up and coming mxicorp.com/company/igc Eric Worre ... has been a leader in the Network Marketing Profession for ...
(Date:7/24/2014)... York, NY (PRWEB) July 25, 2014 ... innovator in health care quality, has been appointed senior ... effective July 21, 2014. In his new role, he ... initiatives. , Dr. Ting has successfully led quality initiatives ... levels. Nationally, he led teams for the Door-to-Balloon Alliance, ...
Breaking Medicine News(10 mins):Health News:Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google 2Health News:Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google 3Health News:Is Europe putting cancer research at risk? 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3
... little is known about these ,in situ, malignancies, experts say ... women with breast cancer in situ in the United States finds ... that number is expected to increase to more than 1 million. ... newly diagnosed breast cancers. It is the early stage of the ...
... , , , , ... stock will be included in the S&P 500 index following the company,s ... be added to the index on Sept. 1, coinciding with its first ... symbol "CFN." , , "Our inclusion in the ...
... test , TUESDAY, Aug. 25 (HealthDay News) -- In a ... found that saliva contains at least 50 microRNAs that could ... levels in the saliva of 50 people with oral squamous ... 50 microRNAs that may be associated with oral cancer. , ...
... cancer survivors decreases their risk of developing the most ... use is associated with a more than four-fold increased ... in the breast opposite, or contralateral, to the initial ... colleagues at Fred Hutchinson Cancer Research Center were published ...
... progressive resistance training also called strength training ... older adults to improve their health. A Virginia Tech ... physiology, and medicine is designing a program to help ... in order to prevent diabetes. "Much attention ...
... Aug. 25 One month ago, July 20, 2009, ... through all 48 states in the continental U.S. in 48 days, a total ... Nagle now has passed well beyond the halfway point on his route, bicycling ... In addition to eyeing a Guinness World Record with his ride, Nagle ...
Cached Medicine News:Health News:More Women Surviving After Early Breast Cancer 2Health News:More Women Surviving After Early Breast Cancer 3Health News:CareFusion Corp to be Included in S&P 500 Index 2Health News:Saliva May Help Spot Oral Cancer Early 2Health News:Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer 2Health News:Researchers evaluate resistance training for diabetes prevention 2Health News:Researchers evaluate resistance training for diabetes prevention 3Health News:College Student's '48 States in 48 Days' Bike Ride Moves Well Beyond the Halfway Point 2
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
The Precedent establishes a new generation of revision hip stems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: